TABLE 3.

Differentially expressed miRNAs following 4h of anti-CCL2 Ab treatment of MDMs.

	anti-CCL2 Ab vs nil		anti-CCL2 Ab vs control Ab
miRNA	FC	p-value	FC	p-value
Up-regulated
hsa-miR-200a-3p	22.40	0.022	n.s.	n.s.
hsa-miR-155-5p	19.10	0.009	10.52	0.026
hsa-miR-146b-5p	5.68	0.040	n.s.	n.s.
hsa-miR-221-3p	4.28	0.010	3.88	0.035
Down-regulated
hsa-miR-501-3p	0.21	0.027	n.s.	n.s.